Dauden E, Escario E, Martos-Cabrera L, Armesto S, et al. Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting. Int J Dermatol 2024 Jan 2. doi: 10.1111/ijd.16915.
PMID: 38168847